Phase 1 Chronic Inducible Urticaria Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults

Chronic Spontaneous UrticariaChronic Inducible Urticaria

Enanta Pharmaceuticals, Inc98 enrolled1 locationNCT07540910

Recruiting

Phase 1

A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria

Healthy SubjectsChronic Inducible UrticariaCold Urticaria+1 more

Granular Therapeutics Limited72 enrolled2 locationsNCT07181369